Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease

David H. Salat, Jeffrey Kaye, Jeri S. Janowsky

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

Objectives: To quantify the contribution of gray and white matter volumes to total prefrontal volume in healthy aging. To determine if prefrontal tissue volumes distinguish healthy aging from Alzheimer disease (AD). Design: Volumes of total prefrontal cortex, prefrontal gray matter, and prefrontal white matter were compared among young healthy elderly (YHE) (n = 14; mean age, 70 years), old healthy elderly (OHE) (n = 14; mean age, 90 years), and subjects with AD (n = 14; mean age, 70 years) by analysis of variance. Additionally, Pearson correlations were performed between volumes and age. Results: Old healthy elderly and subjects with AD had significantly less total prefrontal volume (approximately 15% less in both groups) and prefrontal white matter volume (approximately 30% less and 20% less in the OHE and AD groups, respectively) than YHE, but there were no differences between the OHE and AD groups. There was a significant difference in gray- white matter volume ratio with OHE having a higher ratio than YHE. Subjects with AD did not differ from YHE or OHE in this ratio. There were significant negative correlations between age and total prefrontal volume and age and prefrontal white matter volume in the healthy subjects. Conclusions: In the very old, the decline of white matter volume is disproportionately greater than the decline of gray matter volume. In subjects with AD both gray and white matter loss contribute to the decline of prefrontal volume. This is demonstrated by the gray-white matter ratio that does not differ between YHE and subjects with AD. Thus, it is likely that AD is different from accelerated aging.

Original languageEnglish (US)
Pages (from-to)338-344
Number of pages7
JournalArchives of Neurology
Volume56
Issue number3
StatePublished - Mar 1999

Fingerprint

Alzheimer Disease
Healthy Volunteers
White Matter
Gray Matter
Alzheimer's Disease
Prefrontal Cortex
Analysis of Variance

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. / Salat, David H.; Kaye, Jeffrey; Janowsky, Jeri S.

In: Archives of Neurology, Vol. 56, No. 3, 03.1999, p. 338-344.

Research output: Contribution to journalArticle

Salat, David H. ; Kaye, Jeffrey ; Janowsky, Jeri S. / Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. In: Archives of Neurology. 1999 ; Vol. 56, No. 3. pp. 338-344.
@article{8c6b46b377cd477abbe2371dc2414f0f,
title = "Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease",
abstract = "Objectives: To quantify the contribution of gray and white matter volumes to total prefrontal volume in healthy aging. To determine if prefrontal tissue volumes distinguish healthy aging from Alzheimer disease (AD). Design: Volumes of total prefrontal cortex, prefrontal gray matter, and prefrontal white matter were compared among young healthy elderly (YHE) (n = 14; mean age, 70 years), old healthy elderly (OHE) (n = 14; mean age, 90 years), and subjects with AD (n = 14; mean age, 70 years) by analysis of variance. Additionally, Pearson correlations were performed between volumes and age. Results: Old healthy elderly and subjects with AD had significantly less total prefrontal volume (approximately 15{\%} less in both groups) and prefrontal white matter volume (approximately 30{\%} less and 20{\%} less in the OHE and AD groups, respectively) than YHE, but there were no differences between the OHE and AD groups. There was a significant difference in gray- white matter volume ratio with OHE having a higher ratio than YHE. Subjects with AD did not differ from YHE or OHE in this ratio. There were significant negative correlations between age and total prefrontal volume and age and prefrontal white matter volume in the healthy subjects. Conclusions: In the very old, the decline of white matter volume is disproportionately greater than the decline of gray matter volume. In subjects with AD both gray and white matter loss contribute to the decline of prefrontal volume. This is demonstrated by the gray-white matter ratio that does not differ between YHE and subjects with AD. Thus, it is likely that AD is different from accelerated aging.",
author = "Salat, {David H.} and Jeffrey Kaye and Janowsky, {Jeri S.}",
year = "1999",
month = "3",
language = "English (US)",
volume = "56",
pages = "338--344",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease

AU - Salat, David H.

AU - Kaye, Jeffrey

AU - Janowsky, Jeri S.

PY - 1999/3

Y1 - 1999/3

N2 - Objectives: To quantify the contribution of gray and white matter volumes to total prefrontal volume in healthy aging. To determine if prefrontal tissue volumes distinguish healthy aging from Alzheimer disease (AD). Design: Volumes of total prefrontal cortex, prefrontal gray matter, and prefrontal white matter were compared among young healthy elderly (YHE) (n = 14; mean age, 70 years), old healthy elderly (OHE) (n = 14; mean age, 90 years), and subjects with AD (n = 14; mean age, 70 years) by analysis of variance. Additionally, Pearson correlations were performed between volumes and age. Results: Old healthy elderly and subjects with AD had significantly less total prefrontal volume (approximately 15% less in both groups) and prefrontal white matter volume (approximately 30% less and 20% less in the OHE and AD groups, respectively) than YHE, but there were no differences between the OHE and AD groups. There was a significant difference in gray- white matter volume ratio with OHE having a higher ratio than YHE. Subjects with AD did not differ from YHE or OHE in this ratio. There were significant negative correlations between age and total prefrontal volume and age and prefrontal white matter volume in the healthy subjects. Conclusions: In the very old, the decline of white matter volume is disproportionately greater than the decline of gray matter volume. In subjects with AD both gray and white matter loss contribute to the decline of prefrontal volume. This is demonstrated by the gray-white matter ratio that does not differ between YHE and subjects with AD. Thus, it is likely that AD is different from accelerated aging.

AB - Objectives: To quantify the contribution of gray and white matter volumes to total prefrontal volume in healthy aging. To determine if prefrontal tissue volumes distinguish healthy aging from Alzheimer disease (AD). Design: Volumes of total prefrontal cortex, prefrontal gray matter, and prefrontal white matter were compared among young healthy elderly (YHE) (n = 14; mean age, 70 years), old healthy elderly (OHE) (n = 14; mean age, 90 years), and subjects with AD (n = 14; mean age, 70 years) by analysis of variance. Additionally, Pearson correlations were performed between volumes and age. Results: Old healthy elderly and subjects with AD had significantly less total prefrontal volume (approximately 15% less in both groups) and prefrontal white matter volume (approximately 30% less and 20% less in the OHE and AD groups, respectively) than YHE, but there were no differences between the OHE and AD groups. There was a significant difference in gray- white matter volume ratio with OHE having a higher ratio than YHE. Subjects with AD did not differ from YHE or OHE in this ratio. There were significant negative correlations between age and total prefrontal volume and age and prefrontal white matter volume in the healthy subjects. Conclusions: In the very old, the decline of white matter volume is disproportionately greater than the decline of gray matter volume. In subjects with AD both gray and white matter loss contribute to the decline of prefrontal volume. This is demonstrated by the gray-white matter ratio that does not differ between YHE and subjects with AD. Thus, it is likely that AD is different from accelerated aging.

UR - http://www.scopus.com/inward/record.url?scp=0033062915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033062915&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 338

EP - 344

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 3

ER -